1. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
   Xuefei Sun et al, 2017, Oncotarget CrossRef
2. Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma
   Ziqing Tang et al, 2024, Strahlentherapie und Onkologie CrossRef
3. Review of rituximab in primary CNS lymphoma
   Pawan K. Singh et al, 2020, Journal of the Neurological Sciences CrossRef
4. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma
   Jing Liu et al, 2017, Oncology Reports CrossRef
5. Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
   Ni Fan et al, 2017, Oncotarget CrossRef
6. Advances and challenges in the treatment of primary central nervous system lymphoma
   Hua Yang et al, 2020, Journal of Cellular Physiology CrossRef